Status:
UNKNOWN
Near to Infrared (NIR) Light Neuroprotection in Glaucomatous Optic Neuropathy
Lead Sponsor:
Universidad de Valparaiso
Collaborating Sponsors:
Comisión Nacional de Investigación Científica y Tecnológica
Conditions:
Open Angle Glaucoma
Eligibility:
All Genders
40+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of the study is to evaluate if near-to-infrared light stimulation can improve retinal ganglion cell function in glaucomatous patients.
Detailed Description
Ganglion cell dysfunction in glaucomatous optic neuropathy has been ascribed to ganglion cell electrophysiological inactivation and to apoptotic cell death. Near-to-infrared light stimulation has been...
Eligibility Criteria
Inclusion
- Clinical diagnose of Ocular Hypertension (cup to disk ratio 0,6 or less, normal Humphrey 24-2 visual field with aplanatic IOP over 21 mmHg) or Mild Glaucoma (cup to disk ratio 0,6 to 0,8, characteristic Humphrey 24-2 visual field defect PSD between 3 and 6 dB).
- Visual acuity 20/40 or better
Exclusion
- Diabetic retinopathy, Multiple Sclerosis, Parkinson disease
- Refractive error of 3 diopters or more
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00844389
Start Date
April 1 2009
End Date
March 1 2010
Last Update
October 1 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Servicio de Oftalmología Hospital Van Buren
Valparaíso, Región de Valparaíso, Chile